Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: Field, M. et al. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients.
Field M, Splevins A, Picaut P, van der Schans M, Langenberg J, Noort D, Snyder D, Foster K. Field M, et al. Among authors: picaut p. Toxins (Basel). 2019 Feb 13;11(2):115. doi: 10.3390/toxins11020115. Toxins (Basel). 2019. PMID: 30781899 Free PMC article.
The Expanding Therapeutic Utility of Botulinum Neurotoxins.
Fonfria E, Maignel J, Lezmi S, Martin V, Splevins A, Shubber S, Kalinichev M, Foster K, Picaut P, Krupp J. Fonfria E, et al. Among authors: picaut p. Toxins (Basel). 2018 May 18;10(5):208. doi: 10.3390/toxins10050208. Toxins (Basel). 2018. PMID: 29783676 Free PMC article. Review.
Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?
Huynh Le Maux A, Pignol B, Behr-Roussel D, Blachon JL, Chabrier PE, Compagnie S, Picaut P, Bernabé J, Giuliano F, Denys P. Huynh Le Maux A, et al. Among authors: picaut p. Toxins (Basel). 2015 Dec 17;7(12):5462-71. doi: 10.3390/toxins7124896. Toxins (Basel). 2015. PMID: 26694464 Free PMC article.
Poster 485 Safety and Tolerability of AbobotulinumtoxinA (Dysport) in Children (2-17 Years) with Lower Limb Spasticity Due to Cerebral Palsy: A Pooled Analysis of 8 Clinical Trials.
Matthews D, Camba GC, Pascual-Pascual I, Tilton AH, Gormley M, Mahmood A, Picaut P, Snyder D, Delgado MR. Matthews D, et al. Among authors: picaut p. PM R. 2016 Sep;8(9S):S318. doi: 10.1016/j.pmrj.2016.07.403. Epub 2016 Sep 24. PM R. 2016. PMID: 27673230 No abstract available.
AbobotulinumtoxinA for Equinus Foot Deformity in Cerebral Palsy: A Randomized Controlled Trial.
Delgado MR, Tilton A, Russman B, Benavides O, Bonikowski M, Carranza J, Dabrowski E, Dursun N, Gormley M, Jozwiak M, Matthews D, Maciag-Tymecka I, Unlu E, Pham E, Tse A, Picaut P. Delgado MR, et al. Among authors: picaut p. Pediatrics. 2016 Feb;137(2):e20152830. doi: 10.1542/peds.2015-2830. Epub 2016 Jan 26. Pediatrics. 2016. PMID: 26812925 Clinical Trial.
44 results